BiotechTube
Home/Yarrow Bioscience/Rebecca Frey
RF

Rebecca Frey

President & Chief Executive Officer

Yarrow Bioscience

Therapeutic Areas

Autoimmune DiseasesEndocrinologyOphthalmology

Yarrow Bioscience Pipeline

DrugIndicationPhase
YB-101 (GS-098)Graves' DiseasePhase 1b/2b (Planned)